These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 36985513)

  • 1. Design, synthesis and exploration of novel triazinoindoles as potent quorum-sensing inhibitors and radical quenchers.
    Rasgania J; Gavadia R; Sahu N; Sharma P; Chauhan NS; Saharan V; Kapoor RK; Jakhar K
    Future Med Chem; 2024 Mar; 16(5):399-416. PubMed ID: 38375563
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurodegeneration: can metabolites from
    Cavalloro V; Marchesi N; Linciano P; Rossi D; Campagnoli LIM; Fossati A; Ahmed KM; Malacrida A; Miloso M; Mazzeo G; Abbate S; Longhi G; Ambrosio FA; Costa G; Alcaro S; Pascale A; Martino E; Collina S
    Front Pharmacol; 2024; 15():1309766. PubMed ID: 38370479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Ligand and Structure Based Screening of Potent Quorum Sensing Inhibitors Against Antibiotic Resistance Induced Bacterial Virulence.
    Nandi S
    Recent Pat Biotechnol; 2016; 10(2):195-216. PubMed ID: 27468815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-Resistant Biofilm, Quorum Sensing, Quorum Quenching, and Antibacterial Activities of Indole Derivatives as Potential Eradication Approaches.
    Odularu AT; Afolayan AJ; Sadimenko AP; Ajibade PA; Mbese JZ
    Biomed Res Int; 2022; 2022():9048245. PubMed ID: 36060142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Insights into the Ligand-LsrK Kinase Binding Mode: A Step Forward in the Discovery of Novel Antimicrobial Agents.
    Listro R; Milli G; Pellegrini A; Motta C; Cavalloro V; Martino E; Kirchmair J; Pietrocola G; Rossi D; Linciano P; Collina S
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tackling Antimicrobial Resistance with Small Molecules Targeting LsrK: Challenges and Opportunities.
    Linciano P; Cavalloro V; Martino E; Kirchmair J; Listro R; Rossi D; Collina S
    J Med Chem; 2020 Dec; 63(24):15243-15257. PubMed ID: 33152241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening-based discovery of AI-2 quorum sensing inhibitors that interact with an allosteric hydrophobic site of LsrK and their functional evaluation.
    Shi Q; Wen H; Xu Y; Zhao X; Zhang J; Li Y; Meng Q; Yu F; Xiao J; Li X
    Front Chem; 2023; 11():1185224. PubMed ID: 37292175
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-Based Virtual Screening of LsrK Kinase Inhibitors to Target Quorum Sensing.
    Medarametla P; Gatta V; Kajander T; Laitinen T; Tammela P; Poso A
    ChemMedChem; 2018 Nov; 13(22):2400-2407. PubMed ID: 30178912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Characterization of LsrK as a Quorum Sensing Target and a Comparison between X-ray and Homology Models.
    Medarametla P; Kronenberger T; Laitinen T; Poso A
    J Chem Inf Model; 2021 Mar; 61(3):1346-1353. PubMed ID: 33683884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of AI-2 Quorum Sensing Inhibitors Targeting the LsrK/HPr Protein-Protein Interaction Site by Molecular Dynamics Simulation, Virtual Screening, and Bioassay Evaluation.
    Xu Y; Zeng C; Wen H; Shi Q; Zhao X; Meng Q; Li X; Xiao J
    Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Resistance and Its Drivers-A Review.
    Irfan M; Almotiri A; AlZeyadi ZA
    Antibiotics (Basel); 2022 Oct; 11(10):. PubMed ID: 36290020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Multiple Myeloma Potential of Secondary Metabolites from
    Malacrida A; Cavalloro V; Martino E; Costa G; Ambrosio FA; Alcaro S; Rigolio R; Cassetti A; Miloso M; Collina S
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34771006
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.